Neuroimaging Biomarkers in Parkinson's Disease

Area of Science:

• Neuroscience
• Neurology
• Medical Imaging

Background:

• Parkinson's disease (PD) is a progressive neurodegenerative disorder impacting motor and non-motor functions.
• PD is the fastest-growing neurological disorder, projected to affect over 12 million globally by 2040, posing a significant public health challenge.
• Current treatments for PD are symptomatic, lacking disease-modifying therapies, highlighting the need for prevention strategies.

Purpose of the Study:

• To emphasize the critical role of understanding PD's pathological processes for developing effective prevention and treatment strategies.
• To highlight the potential of advanced multimodal neuroimaging techniques in advancing PD research.
• To explore the utility of neuroimaging biomarkers in clinical applications, such as differential diagnosis and translational research.

Main Methods:

• Utilizing advanced multimodal neuroimaging techniques to identify biomarkers.
• Analyzing biomarkers at multiple levels, from neurotransmitters to neural networks.
• Investigating the clinical applications of neuroimaging biomarkers in PD diagnosis and research.

Main Results:

• Neuroimaging techniques provide unique biomarkers offering insights into PD's complex pathology.
• These biomarkers have demonstrated value in the differential diagnosis of PD.
• The identified biomarkers facilitate a deeper understanding of PD at various biological levels.

Conclusions:

• Understanding PD pathology through advanced neuroimaging is crucial for developing preventative measures and novel treatments.
• Neuroimaging biomarkers are becoming increasingly specific, accessible, and vital for translational research in PD.
• The identified neuroimaging biomarkers hold promise for improving PD diagnosis and guiding future therapeutic development.